{[μ-N,N′-Bis(salicylidene)-1,3-propanediaminato](N,N-dimethylformamide)(methanol)nickel(II)}dibromozinc(II)

Abstract

In the crystals structure of the title compound, [ZnNiBr2(C17H16N2O2)(C3H7NO)(CH4O)], there is a heterodinuclear nickel(II)–zinc(II) complex mol­ecule, with the Ni2+ and Zn2+ ions bridged by the phenolic O atoms of the Schiff base N,N′-bis­(salicyl­idene)-2,2′-di­methyl-1,3-propane­diaminate (SALPD2−, C17H16N2O2) ligand. The coordination geometry around the Ni2+ ion is irregular octahedral, involving two O and two N donors of the SALPD2− ligand in the equatorial plane, and O atoms of di­methyl­form­amide and methanol in the apical positions. The Zn2+ ion has a distorted tetrahedral coordination.